Hi RYNZN, I think that's an excellent point he brings up. I feel exactly the same but just couldn't articulate my thoughts. A lot of what's happened and is happening at this company is often a communication opportunity lost on the average IQ which populates these forums, including me. The medical numerical data needs to be translated into meaningful words for the ice cream licking public like us. Our executive descendants were terrible at it so it thrills me to hear our new leaders have identified some company/shareholder shortcomings and want to fix it. The whole range of investors need to be addressed so a combination or graphs with dots all over the place and a narrative which describes all those dots is important. A third party expert comment that focuses on disease meaningfulness always helps too. Thanks for bringing this up and feel free to feedback to him should you agree.
ANP Price at posting:
6.3¢ Sentiment: Buy Disclosure: Held
